The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Baranov A.A.

Meshalkin National Medical Research Center

Badoyan A.G.

Meshalkin National Medical Research Center

Khelimskiy D.A.

Meshalkin National Medical Research Center

Cydenova A.Yu.

Meshalkin National Medical Research Center;
Novosibirsk State Medical University

Naydenov R.A.

Meshalkin National Medical Research Center

Boboshko V.A.

Meshalkin National Medical Research Center

Lomivorotov V.V.

Meshalkin National Medical Research Center

Belov V.A.

Sukhanov Federal Center of Cardiovascular Surgery

Arutyunyan V.B.

Sukhanov Federal Center of Cardiovascular Surgery

Kadyraliev B.K.

Sukhanov Federal Center of Cardiovascular Surgery

Krestyaninov O.V.

Meshalkin National Medical Research Center;
Novosibirsk State Medical University

Predictors and impact of myocardial injury (VARC-3 criteria) after transcatheter aortic valve implantation

Authors:

Baranov A.A., Badoyan A.G., Khelimskiy D.A., Cydenova A.Yu., Naydenov R.A., Boboshko V.A., Lomivorotov V.V., Belov V.A., Arutyunyan V.B., Kadyraliev B.K., Krestyaninov O.V.

More about the authors

Journal: Russian Journal of Cardiology and Cardiovascular Surgery. 2024;17(5): 489‑498

DOI: 10.17116/kardio202417051489

Read: 1247 times

Download PDF (RU)
Contact the author
Table of contents

PREDICTORS AND IMPACT OF MYOCARDIAL INJURY (VARC-3 CRITERIA) AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION
PREDICTORS AND IMPACT OF MYOCARDIAL INJURY (VARC-3 CRITERIA) AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION

To cite this article:

Baranov AA, Badoyan AG, Khelimskiy DA, et al. . Predictors and impact of myocardial injury (VARC-3 criteria) after transcatheter aortic valve implantation. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;17(5):489‑498. (In Russ.)
https://doi.org/10.17116/kardio202417051489

 
 
ЭндоКард
Подписка 2026 Кардиология и сердечно-сосудистая хирургия (Russian Journal of Cardiology and Cardiovascular Surgery)
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Technical features of aortic valve prosthesis fixa­tion to mini­mize pressure gradient in postoperative period. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(1):41-44
Clinical outcomes after transcatheter aortic valve implantation in patients with concomitant coro­nary artery disease. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(1):45-52
Predictors of myocardial infa­rction in patients with stable peri­pheral artery disease. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(1):61-65
What we have to change in the treatment of ST-segment elevation myocardial infa­rction?. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):183-190
Surgical explantation of transcatheter aortic valve for para­prosthetic regu­rgitation and leaflet dege­neration. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(2):226-229
Myocardial infa­rction in young age. Russian Journal of Preventive Medi­cine. 2024;(11):77-84
Cere­bral protection in transcatheter aortic valve implantation. Piro­gov Russian Journal of Surgery. 2024;(12-2):150-158
Fibrin mono­mer in diagnosis of cardiovascular diseases. Russian Cardiology Bulletin. 2024;(4-2):113-120
Prevalence and role of elevated serum lipo­protein(a) in patients with myocardial infa­rction acco­rding to the Russian regi­ster of acute myocardial infa­rction REGION-MI. Russian Cardiology Bulletin. 2025;(1):39-48
Serum expression of microRNA-21, microRNA-125a, microRNA-125b, microRNA-214 in coro­nary artery disease patients. Russian Cardiology Bulletin. 2025;(2):13-19
Abstract:

OBJECTIVE

To determine the factors associated with periprocedural increase in high-sensitive troponin I (hsTrI) after transcatheter aortic valve implantation (TAVI), as well as to evaluate prognostic significance of periprocedural myocardial injury (PMI) on survival of patients after TAVI.

MATERIAL AND METHODS

A retrospective study included 149 patients who underwent TAVI for severe aortic stenosis. Analysis included patients with available assessment of hsTrI before and after TAVI. According to postoperative hsTrI (VARC-3 criteria), all patients were divided into 2 groups: group 1 — patients with 70 times excess of the upper limit of normal (ULN) hsTrI («hsTrI≥70×ULN»), group 2 — patients with hsTrI <70xULN («hsTrI<70×ULN»).

RESULTS

PMI occurred in 18.8% of patients. According to multivariate regression analysis, independent predictors of 70-fold increase in hsTrI were age (OR 1.13, 95% CI 1.01—1.26, p=0.03), female sex (OR 15.6, 95% CI 2.57—95.20, p=0.003) and bioprosthesis implantation depth (OR 1.46, 95% CI 1.10—1.94, p=0.009). There were no significant differences in survival rate (85.7% vs. 90.9%, plog-rank=0.48).

CONCLUSION

Age, female gender and bioprosthesis implantation depth were independent predictors of PMI after TAVI. Myocardial injury after TAVI does not affect long-term survival of patients.

Keywords:

aortic stenosis
transcatheter aortic valve implantation
troponin
myocardial infarction
myocardial injury

Authors:

Baranov A.A.

Meshalkin National Medical Research Center

Badoyan A.G.

Meshalkin National Medical Research Center

Khelimskiy D.A.

Meshalkin National Medical Research Center

Cydenova A.Yu.

Meshalkin National Medical Research Center;
Novosibirsk State Medical University

Naydenov R.A.

Meshalkin National Medical Research Center

Boboshko V.A.

Meshalkin National Medical Research Center

Lomivorotov V.V.

Meshalkin National Medical Research Center

Belov V.A.

Sukhanov Federal Center of Cardiovascular Surgery

Arutyunyan V.B.

Sukhanov Federal Center of Cardiovascular Surgery

Kadyraliev B.K.

Sukhanov Federal Center of Cardiovascular Surgery

Krestyaninov O.V.

Meshalkin National Medical Research Center;
Novosibirsk State Medical University

Received:

15.08.2023

Accepted:

28.11.2023

Close metadata

References:

  1. Smith CR, Leon MB, Mack MJ, et al. PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187-2198. https://doi.org/10.1056/NEJMoa1103510
  2. Reardon MJ, Van Mieghem NM, Popma JJ, et al. SURTAVI Investigators. Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2017;376(14):1321-1331. https://doi.org/10.1056/NEJMoa1700456
  3. Mack MJ, Leon MB, Thourani VH, et al. PARTNER 3 Investigators. Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients. N Engl J Med. 2019;380(18):1695-1705. https://doi.org/10.1056/NEJMoa1814052
  4. Krestyaninov OV, Baranov AA, Ibragimov RU, et al. In-hospital outcomes of transcatheter aortic valve implantation procedure: data of single-center registry. The Siberian Journal of Clinical and Experimental Medicine. 2022;37(2):49-56. (In Russ.). https://doi.org/10.29001/2073-8552-2022-37-2-49-56
  5. Généreux P, Piazza N, Alu MC, et al. Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. Eur Heart J. 2021;42(19):1825-1857. https://doi.org/10.1093/eurheartj/ehaa799
  6. Kahlert P, Al-Rashid F, Plicht B, et al. Myocardial injury during transfemoral transcatheter aortic valve implantation: an intracoronary Doppler and cardiac magnetic resonance imaging study. EuroIntervention. 2016;11(12):1401-1408. https://doi.org/10.4244/EIJY15M05_10
  7. Kim WK, Rolf A, Liebetrau C, et al. Detection of myocardial injury by CMR after transcatheter aortic valve replacement. J Am Coll Cardiol. 2014;64(4):349-357.  https://doi.org/10.1016/j.jacc.2014.03.052
  8. Guney MC, Keles T, Karaduman BD, et al. Predictors and Prognostic Implications of Myocardial Injury After Transcatheter Aortic Valve Replacement. Tex Heart Inst J. 2022;49(4):e207380. https://doi.org/10.14503/THIJ-20-7380
  9. Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. Eur Heart J. 2012;33(19):2403-2418. https://doi.org/10.1093/ejcts/ezs533
  10. Moussa ID, Klein LW, Shah B, et al. Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI). J Am Coll Cardiol. 2013;62(17):1563-1570. https://doi.org/10.1016/j.jacc.2013.08.720
  11. Vahanian A, Beyersdorf F, Praz F, et al. ESC/EACTS Scientific Document Group. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2021;43(7):561-632.  https://doi.org/10.1093/eurheartj/ehab395
  12. Nashef SAM, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41(4):734-744.  https://doi.org/10.1093/ejcts/ezs043
  13. Shahian DM, O’Brien SM, Filardo G, et al. Society of Thoracic Surgeons Quality Measurement Task Force. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: Part 1 — coronary artery bypass grafting surgery. Ann Thorac Surg. 2009;88(1 Suppl):S2-S22.  https://doi.org/10.1016/j.athoracsur.2009.05.053
  14. Real C, Avvedimento M, Nuche J, et al. Myocardial Injury After Transcatheter Aortic Valve Replacement According to VARC-3 Criteria. JACC Cardiovasc Interv. 2023;16:1221-1232. https://doi.org/10.1016/j.jcin.2023.03.022
  15. White M, Baral R, Ryding A, et al. Biomarkers Associated with Mortality in Aortic Stenosis: A Systematic Review and Meta-Analysis. Medical Sciences. 2020;9(2):29.  https://doi.org/10.3390/medsci9020029
  16. Sharma V, Dey T, Sankaramangalam K, et al. (2019). Prognostically Significant Myocardial Injury in Patients Undergoing Transcatheter Aortic Valve Replacement. Journal of the American Heart Association. 2021;8(14). https://doi.org/10.1161/jaha.118.011889
  17. Wang J, Liu S, Han X, et al. Impact of Chronic Kidney Disease on the Prognosis of Transcatheter Aortic Valve Replacement in Patients with Aortic Stenosis: A Meta-Analysis of 133624 Patients. Ann Thorac Cardiovasc Surg. 2022 Apr 20;28(2):83-95.  https://doi.org/10.5761/atcs.ra.21-00187
  18. Allende R, Webb JG, Munoz-Garcia AJ, et al. Advanced chronic kidney disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes and prognostic markers from a large cohort of patients. Eur Heart J. 2014;35:2685-2696. https://doi.org/10.1093/eurheartj/ehu175
  19. Chakravarty T, Van Belle E, Jilaihawi H, et al. Meta-analysis of the impact of mitral regurgitation on outcomes after transcatheter aortic valve implantation. Am J Cardiol. 2015 Apr 1;115(7):942-949.  https://doi.org/10.1016/j.amjcard.2015.01.022
  20. Doldi PM, Steffen J, Stolz L, et al. Impact of mitral regurgitation aetiology on the outcomes of transcatheter aortic valve implantation. EuroIntervention. 2023;19(6):526-536.  https://doi.org/10.4244/EIJ-D-22-01062
  21. Brinkert M, De Boeck B, Stämpfli SF, et al. Predictors of paravalvular leak following implantation of the ACURATE neo transcatheter heart valve: the PREDICT PVL study. Open Heart. 2020;7:e001391. https://doi.org/10.1136/openhrt-2020-001391
  22. Sá MP, Jacquemyn X, Van den Eynde J, et al. Impact of Paravalvular Leak on Outcomes After Transcatheter Aortic Valve Implantation: Meta-Analysis of Kaplan-Meier-derived Individual Patient Data. Struct Heart. 2022;7(2):100118. https://doi.org/10.1016/j.shj.2022.100118
  23. Stundl A, Schulte R, Lucht H, et al. Periprocedural myocardial injury depends on transcatheter heart valve type but does not predict mortality in patients after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2017;10(15):1550-1560. https://doi.org/10.1016/j.jcin.2017.05.029
  24. De Marzo V, Crimi G, Vercellino M, et al. Impact of bioprosthetic valve type on peri-procedural myocardial injury and mortality after transcatheter aortic valve replacement. Heart Vessels. 2021;36:1746-1755. https://doi.org/10.1007/s00380-021-01861-8
  25. Koskinas KC, Stortecky S, Franzone A, et al. Post-procedural troponin elevation and clinical outcomes following transcatheter aortic valve implantation. J Am Heart Assoc. 2016;5(2):e002430. https://doi.org/10.1161/jaha.115.002430
  26. Michail M, Cameron JN, Nerlekar N, et al. Periprocedural myocardial injury predicts short- and long-term mortality in patients undergoing transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2018;11(11):e007106. https://doi.org/10.1161/circinterventions.118.007106
  27. Koifman E, Garcia-Garcia HM, Alraies MC, et al. Correlates and significance of elevation of cardiac biomarkers elevation following transcatheter aortic valve implantation. Am J Cardiol. 2017;120(5):850-856  https://doi.org/10.1016/j.amjcard.2017.05.059
  28. Reiter M, Twerenbold R, Reichlin T, et al. Early diagnosis of acute myocardial infarction in patients with pre-existing coronary artery disease using more sensitive cardiac troponin assays. Eur Heart J. 2012;33:988-997.  https://doi.org/10.1093/eurheartj/ehr376
  29. Guedeney P, Chevrot G, Collet JP. VARC-3 Criteria: Adding Prognosis to Injury. JACC Cardiovasc Interv. 2023;16(10):1233-1235. https://doi.org/10.1016/j.jcin.2023.04.012
  30. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol. 2011;57(3):253-269.  https://doi.org/10.1016/j.jacc.2010.12.005
  31. Holmes DR Jr, Mack MJ, Kaul S, et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol. 2012;59(13):1200-1254. https://doi.org/10.1016/j.jacc.2012.01.001
  32. Rodes-Cabau J, Gutierrez M, Bagur R, et al. Incidence, predictive factors, and prognostic value of myocardial injury following uncomplicated transcatheter aortic valve implantation. J Am Coll Cardiol. 2011;57:1988-1999. https://doi.org/10.1016/j.jacc.2010.11.060
  33. Thygesen K, Alpert JS, Jaffe AS, et al. Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). Circulation. 2018;138(20):e618-e651. https://doi.org/10.1093/eurheartj/ehy462
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.